Magnetic resonance imaging in acute ischemic stroke treatment
- PMID: 25328872
- PMCID: PMC4200598
- DOI: 10.5853/jos.2014.16.3.131
Magnetic resonance imaging in acute ischemic stroke treatment
Abstract
Although intravenous administration of tissue plasminogen activator is the only proven treatment after acute ischemic stroke, there is always a concern of hemorrhagic risk after thrombolysis. Therefore, selection of patients with potential benefits in overcoming potential harms of thrombolysis is of great importance. Despite the practical issues in using magnetic resonance imaging (MRI) for acute stroke treatment, multimodal MRI can provide useful information for accurate diagnosis of stroke, evaluation of the risks and benefits of thrombolysis, and prediction of outcomes. For example, the high sensitivity and specificity of diffusion-weighted image (DWI) can help distinguish acute ischemic stroke from stroke-mimics. Additionally, the lesion mismatch between perfusion-weighted image (PWI) and DWI is thought to represent potential salvageable tissue by reperfusion therapy. However, the optimal threshold to discriminate between benign oligemic areas and the penumbra is still debatable. Signal changes of fluid-attenuated inversion recovery image within DWI lesions may be a surrogate marker for ischemic lesion age and might indicate risks of hemorrhage after thrombolysis. Clot sign on gradient echo image may reflect the nature of clot, and their location, length and morphology may provide predictive information on recanalization by reperfusion therapy. However, previous clinical trials which solely or mainly relied on perfusion-diffusion mismatch for patient selection, failed to show benefits of MRI-based thrombolysis. Therefore, understanding the clinical implication of various useful MRI findings and comprehensively incorporating those variables into therapeutic decision-making may be a more reasonable approach for expanding the indication of acute stroke thrombolysis.
Keywords: Acute ischemic stroke; Magnetic resonance image; Thrombolysis.
Conflict of interest statement
The authors have no financial conflicts of interest.
Figures







Similar articles
-
[Intravenous administration of a tissue plasminogen activator beyond 3 hours of the onset of acute ischemic stroke--MRI-based decision making].Brain Nerve. 2008 Oct;60(10):1173-80. Brain Nerve. 2008. PMID: 18975605 Review. Japanese.
-
Trial design and reporting standards for intra-arterial cerebral thrombolysis for acute ischemic stroke.Stroke. 2003 Aug;34(8):e109-37. doi: 10.1161/01.STR.0000082721.62796.09. Epub 2003 Jul 17. Stroke. 2003. PMID: 12869717
-
Monitoring intravenous recombinant tissue plasminogen activator thrombolysis for acute ischemic stroke with diffusion and perfusion MRI.Stroke. 2000 Jun;31(6):1318-28. doi: 10.1161/01.str.31.6.1318. Stroke. 2000. PMID: 10835451
-
The role of diffusion- and perfusion-weighted magnetic resonance imaging in drug development for ischemic stroke: from laboratory to clinics.Curr Vasc Pharmacol. 2004 Oct;2(4):343-55. doi: 10.2174/1570161043385493. Curr Vasc Pharmacol. 2004. PMID: 15320814 Review.
-
Extension of therapeutic window in ischemic stroke by selective mismatch imaging.Int J Stroke. 2019 Jun;14(4):351-358. doi: 10.1177/1747493019840936. Epub 2019 Apr 1. Int J Stroke. 2019. PMID: 30935350 Review.
Cited by
-
Usefulness of voxel-based lesion mapping for predicting motor recovery in subjects with basal ganglia hemorrhage: A preliminary study with 2 case reports.Medicine (Baltimore). 2016 Jun;95(23):e3838. doi: 10.1097/MD.0000000000003838. Medicine (Baltimore). 2016. PMID: 27281090 Free PMC article.
-
Imaging Guidance for Therapeutic Delivery: The Dawn of Neuroenergetics.Neurotherapeutics. 2020 Apr;17(2):522-538. doi: 10.1007/s13311-020-00843-4. Neurotherapeutics. 2020. PMID: 32240530 Free PMC article. Review.
-
Estimating the volume of penumbra in rodents using DTI and stack-based ensemble machine learning framework.Eur Radiol Exp. 2024 May 15;8(1):59. doi: 10.1186/s41747-024-00455-z. Eur Radiol Exp. 2024. PMID: 38744784 Free PMC article.
-
Changes in Cerebral Blood Flow and Diffusion-Weighted Imaging Lesions After Intracerebral Hemorrhage.Transl Stroke Res. 2022 Oct;13(5):686-706. doi: 10.1007/s12975-022-00998-6. Epub 2022 Mar 19. Transl Stroke Res. 2022. PMID: 35305264 Review.
-
Application of Multimodal Magnetic Resonance Imaging in Green Channel of Acute and Hyperacute Ischemic Stroke.Contrast Media Mol Imaging. 2022 Jul 22;2022:2452282. doi: 10.1155/2022/2452282. eCollection 2022. Contrast Media Mol Imaging. 2022. PMID: 35935321 Free PMC article.
References
-
- The National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group. Tissue plasminogen activator for acute ischemic stroke. N Engl J Med. 1995;333:1581–1587. - PubMed
-
- Hacke W, Kaste M, Bluhmki E, Brozman M, Davalos A, Guidetti D, et al. Thrombolysis with alteplase 3 to 4.5 hours after acute ischemic stroke. N Engl J Med. 2008;359:1317–1329. - PubMed
-
- Khatri R, McKinney AM, Swenson B, Janardhan V. Blood-brain barrier, reperfusion injury, and hemorrhagic transformation in acute ischemic stroke. Neurology. 2012;79:S52–S57. - PubMed
-
- Baird AE, Warach S. Magnetic resonance imaging of acute stroke. J Cereb Blood Flow Metab. 1998;18:583–609. - PubMed
-
- Campbell BC, Tu HT, Christensen S, Desmond PM, Levi CR, Bladin CF, et al. Assessing response to stroke thrombolysis: validation of 24-hour multimodal magnetic resonance imaging. Arch Neurol. 2012;69:46–50. - PubMed
Publication types
LinkOut - more resources
Full Text Sources
Other Literature Sources